Pharma Journalist

Developments in Protein Engineering An interview with panelist: Maria Lucas, CEO, Zymvol

By Pharma Journalist on September 14, 2021

Related Posts

7th Operationalize: Expanded Access Programs Summit East Unveils 2027 Agenda

As AI and ICH M15 Transform Drug Development, Industry Leaders Convene to Advance Model-Informed Decision Making

Industry Leaders Explore the Future of RNA Therapeutics Beyond Splicing

Direct RNA Binding Emerges as a Powerful Approach for Functional Disease Modulation

AI, Structure Prediction and Advanced Computational Tools Transform RNA Target Discovery

New Preclinical Data and Translational Advances Set to Take Center Stage at RNA-Targeted Drug Discovery Summit

FDA, Health Canada & Leading Biopharma Organizations Unite at the 2nd Model-Informed Drug Development Summit
Comments (0)
Add Comment